10X Genomics Inc (TXG) — Financial Flexibility Index
10X Genomics Inc (TXG) has a Financial Flexibility Index of 0.18x as of September 2025. Free cash flow of $43.90 Million (operating CF $43.21 Million minus capex $687.00K) represents 0% of total liabilities ($241.03 Million). Check TXG strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
10X Genomics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for 10X Genomics Inc across 8 annual periods. See TXG working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for 10X Genomics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for 10X Genomics Inc. For the full company profile including market capitalisation, see 10X Genomics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.09x | $19.06 Million | $6.66 Million | $208.50 Million | ▼ -40.3% |
| 2023 | 0.15x | $34.33 Million | $-15.20 Million | $224.10 Million | ▼ -65.1% |
| 2022 | 0.44x | $98.06 Million | $-33.61 Million | $223.24 Million | ▲ +10.6% |
| 2021 | 0.40x | $79.91 Million | $-21.37 Million | $201.26 Million | ▲ +142.1% |
| 2020 | -0.94x | $-179.50 Million | $-217.90 Million | $190.27 Million | ▼ -326.5% |
| 2019 | 0.42x | $77.39 Million | $34.63 Million | $185.84 Million | ▲ +305.7% |
| 2018 | -0.20x | $-69.70 Million | $-76.41 Million | $344.30 Million | ▼ -448.5% |
| 2017 | -0.04x | $-6.94 Million | $-10.70 Million | $188.12 Million | — |